Hayat Pharmaceuticals Consulting

General

6 GMP Compliance Gaps Regulators AlwaysFind — And How to Close Them Before YourNext Inspection

GMP Compliance · FDA Inspection Readiness · 2026 6 GMP Compliance Gaps Regulators Always Find — And How to Close Them Before Your Next Inspection In 2026, over 60% of critical inspection findings trace back to weak pharmaceutical quality systems, not the product. Here is what FDA inspectors look for, and how to stay ahead […]

6 GMP Compliance Gaps Regulators AlwaysFind — And How to Close Them Before YourNext Inspection Read More »

Process Validation in 2026: Meeting FDA and EMA Expectations

Process Validation in 2026: Meeting FDA and EMA Expectations “Process validation is not a one-time event. It is a lifecycle commitment that links science, risk management, and regulatory compliance from Day 1 through commercial manufacture.” In 2026, pharmaceutical manufacturers face a regulatory environment that is more data-driven, more transparent, and more demanding than ever before.

Process Validation in 2026: Meeting FDA and EMA Expectations Read More »

How Hayat Pharmaceuticals Consulting Helps Biotech Startups Navigate FDA Approval

How Hayat Pharmaceuticals Consulting Helps Biotech Startups Building a biotech startup is one of the most ambitious things a scientist or entrepreneur can do. You have a molecule with potential. You have a vision for how it could change patients’ lives. But between that vision and a commercially approved drug lies one of the most

How Hayat Pharmaceuticals Consulting Helps Biotech Startups Navigate FDA Approval Read More »

Global Supply Chain & Strategic Sourcing Solutions for Pharmaceutical Innovation

Global Supply Chain & Strategic Sourcing Solutions for Pharmaceutical Innovation Every drug that is administered to patients relies on a well-organized network of manufacturers, suppliers, labs and regulatory agencies. From scientific discovery to a market-ready pharmaceutical product, it requires various starting materials, intermediate and active pharmaceutical ingredients (APIs) along with rigorous analytical testing to guarantee

Global Supply Chain & Strategic Sourcing Solutions for Pharmaceutical Innovation Read More »

Integrated Analytical and Stability Solutions for Product Development

Integrated Analytical and Stability Solutions for Product Development The journey of transforming a pharmaceutical compound from discovery to commercial production is one of the most difficult processes in the life sciences sector. Although early-stage discoveries frequently show encouraging biological activity, converting these compounds into stable, manufacturable and legally compliant products necessitates a strong analytical and stability approach.

Integrated Analytical and Stability Solutions for Product Development Read More »

Advancing Pharmaceutical Formulation Development

Advancing Pharmaceutical Formulation Development The formulation of pharmaceutical drugs is a crucial step for identifying the appropriate dosage form, composition and production method in the drug development process. A drug may fail phase I clinical trials prior to effective absorption, if it cannot be administered in a stable form and limiting its market potential. In

Advancing Pharmaceutical Formulation Development Read More »

Process Chemistry Excellence: From Discovery to Commercialization

Process Chemistry Excellence: From Discovery to Commercialization In pharmaceutical development process, finding a promising drug candidate is only the beginning of the journey. The true difficulty is turning that drug into a powerful, scalable, regulatory compliant medicine that is prepared for commercial success. From inefficient synthetic paths and uncontrolled impurity profiles to unstable solid forms

Process Chemistry Excellence: From Discovery to Commercialization Read More »